: Short-term use of air purifiers has been associated with significant decreases in systolic and diastolic blood pressure, particularly in highly polluted environments.

), volatile organic compounds (VOCs), and biological allergens—has been linked to nearly 3.8 million premature deaths annually. Air purifiers, particularly those utilizing High-Efficiency Particulate Air (HEPA) technology, serve as a primary intervention to mitigate these risks. 1. Mitigation of Respiratory Conditions

: HEPA filters are designed to capture 99.97% of airborne particles as small as 0.3 microns, including pollen, dust mites, and pet dander. Clinical trials have shown that children with asthma may experience up to a 24% drop in airway resistance when purifiers are used.

: Studies have observed reductions in circulating biomarkers of inflammation, such as C-reactive protein, following indoor air filtration.

Emerging research suggests that air purification provides benefits beyond the lungs by reducing systemic inflammation.

Indoor air quality (IAQ) is a critical yet often overlooked component of public health. With individuals spending approximately 87% of their time indoors, exposure to household air pollution—comprising fine particulate matter ( PM2.5cap P cap M sub 2.5

The most established benefit of air purifiers is the reduction of triggers for chronic respiratory diseases.